https://orcid.org/0000-0002-3845-9445
Overview
Qingyi Wei, MD, PhD, Professor in the Department of Medicine, is Associate Director for Cancer Control and Population Sciences, Co-leader of CCPS and Co-leader of Epidemiology and Population Genomics (Focus Area 1). He is a professor of Medicine and an internationally recognized epidemiologist focused on the molecular and genetic epidemiology of head and neck cancers, lung cancer, and melanoma. His research focuses on biomarkers and genetic determinants for the DNA repair deficient phenotype and variations in cell death. He is Editor-in-Chief of the open access journal "Cancer Medicine" and Associate Editor-in-Chief of the International Journal of Molecular Epidemiology and Genetics.
Area of Expertise: Epidemiology
Area of Expertise: Epidemiology
Current Duke Appointments & Affiliations
Professor Emeritus in Population Health Sciences
·
2024 - Present
Population Health Sciences,
Basic Science Departments
Recent Scholarly Works
Potentially Functional Variants in FCER1A and PLCG2, Two B Cell-Related Immune Genes Predict the Survival of Chinese Gastric Cancer Patients.
Journal article Mol Carcinog · August 2026 B cells are integral components of the tumor microenvironment (TME) and influence the progression, prognosis, and immunotherapy response of gastric cancer (GC). However, the prognostic relevance of germline variants in B cell-related immune genes remains u ... Full text Link to item CitePotentially Functional Variants of DCTD and ENTPD2 in the Metabolism of Nucleotide Pathway Genes Predict Survival of HBV-Related Hepatocellular Carcinoma Patients.
Journal article Cancers (Basel) · July 14, 2026 Purpose: Nucleotide metabolism plays a critical role in cancer development, but the prognostic significance of genetic variants in nucleotide metabolism genes for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients remains unclear. Meth ... Full text Link to item CiteRural-urban disparities in cardiovascular and other competing risk of death among cancer patients.
Journal article J Adv Res · July 2026 INTRODUCTION: Rural-urban disparity of cancer is a major public health problem, with an unclear gap in noncancer death. It is important to evaluate rural-urban disparities in cardiovascular diseases (CVDs) and other competing death among cancer patients. O ... Full text Link to item CiteRecent Grants
A multidisciplinary study of biological disparities in NASH progression and response to statins to inform personalized liver cancer chemoprevention in NAFLD
ResearchCollaborating Investigator · Awarded by Department of Defense · 2020 - 2025Postdoctoral Training in Genomic Medicine Research
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2017 - 2023Helicobacter pylori blood biomarker for gastric cancer risk in East Asia
ResearchCo Investigator · Awarded by National Institutes of Health · 2017 - 2020View All Grants
Education
Johns Hopkins Unversity, Bloomberg School of Public Health ·
1993
Ph.D.
Nanjing Medical University (China) ·
1983
B.M.